Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

NASDAQ:CLNE - Nasdaq - US1844991018 - Common Stock - Currency: USD

1.89  0 (0%)

Premarket: 1.9 +0.01 (+0.53%)

Fundamental Rating

4

Taking everything into account, CLNE scores 4 out of 10 in our fundamental rating. CLNE was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CLNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLNE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CLNE had positive earnings in the past year.
CLNE had a positive operating cash flow in the past year.
CLNE had negative earnings in each of the past 5 years.
Each year in the past 5 years CLNE had a positive operating cash flow.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE has a Return On Assets of -17.88%. This is amonst the worse of the industry: CLNE underperforms 90.05% of its industry peers.
The Return On Equity of CLNE (-33.45%) is worse than 82.46% of its industry peers.
Industry RankSector Rank
ROA -17.88%
ROE -33.45%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

With a Gross Margin value of 30.77%, CLNE perfoms like the industry average, outperforming 41.23% of the companies in the same industry.
In the last couple of years the Gross Margin of CLNE has declined.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLNE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLNE has more shares outstanding
The debt/assets ratio for CLNE is higher compared to a year ago.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.54, we must say that CLNE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.54, CLNE is doing worse than 72.99% of the companies in the same industry.
CLNE has a debt to FCF ratio of 46.58. This is a negative value and a sign of low solvency as CLNE would need 46.58 years to pay back of all of its debts.
CLNE has a Debt to FCF ratio of 46.58. This is comparable to the rest of the industry: CLNE outperforms 42.65% of its industry peers.
CLNE has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
CLNE has a Debt to Equity ratio (0.46) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 46.58
Altman-Z -0.54
ROIC/WACCN/A
WACC9.72%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.82 indicates that CLNE has no problem at all paying its short term obligations.
CLNE has a Current ratio of 2.82. This is amongst the best in the industry. CLNE outperforms 83.89% of its industry peers.
A Quick Ratio of 2.50 indicates that CLNE has no problem at all paying its short term obligations.
CLNE's Quick ratio of 2.50 is amongst the best of the industry. CLNE outperforms 83.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.5
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

CLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 166.67%, which is quite impressive.
CLNE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.00% yearly.
Looking at the last year, CLNE shows a small growth in Revenue. The Revenue has grown by 4.85% in the last year.
The Revenue has been growing slightly by 3.86% on average over the past years.
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%200%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%0.05%

3.2 Future

The Earnings Per Share is expected to grow by 35.63% on average over the next years. This is a very strong growth
CLNE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.46% yearly.
EPS Next Y-564.1%
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%
EPS Next 5Y35.63%
Revenue Next Year2.76%
Revenue Next 2Y6.02%
Revenue Next 3Y6.94%
Revenue Next 5Y22.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.50, the valuation of CLNE can be described as expensive.
Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than 62.09% of the companies in the same industry.
When comparing the Price/Earnings ratio of CLNE to the average of the S&P500 Index (26.98), we can say CLNE is valued inline with the index average.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 31.5
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

CLNE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CLNE is more expensive than 69.19% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLNE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 70.94
EV/EBITDA 23.95
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A cheap valuation may be justified as CLNE's earnings are expected to decrease with -45.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%

0

5. Dividend

5.1 Amount

CLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (6/27/2025, 8:00:00 PM)

Premarket: 1.9 +0.01 (+0.53%)

1.89

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners49.9%
Inst Owner Change-2.8%
Ins Owners1.14%
Ins Owner Change0.99%
Market Cap417.65M
Analysts84
Price Target4.33 (129.1%)
Short Float %6.52%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)145.02%
Min EPS beat(2)106%
Max EPS beat(2)184.05%
EPS beat(4)4
Avg EPS beat(4)151.1%
Min EPS beat(4)106%
Max EPS beat(4)185.77%
EPS beat(8)8
Avg EPS beat(8)152.93%
EPS beat(12)11
Avg EPS beat(12)112.95%
EPS beat(16)12
Avg EPS beat(16)138.84%
Revenue beat(2)2
Avg Revenue beat(2)4.14%
Min Revenue beat(2)3.83%
Max Revenue beat(2)4.45%
Revenue beat(4)3
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)4.45%
Revenue beat(8)4
Avg Revenue beat(8)-2.73%
Revenue beat(12)6
Avg Revenue beat(12)-0.34%
Revenue beat(16)7
Avg Revenue beat(16)-7.25%
PT rev (1m)-33.91%
PT rev (3m)-36.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.18%
EPS NY rev (1m)24.53%
EPS NY rev (3m)-123.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)3.12%
Revenue NY rev (3m)3.16%
Valuation
Industry RankSector Rank
PE 31.5
Fwd PE N/A
P/S 1
P/FCF 70.94
P/OCF 4.89
P/B 0.7
P/tB 0.71
EV/EBITDA 23.95
EPS(TTM)0.06
EY3.17%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.03
FCFY1.41%
OCF(TTM)0.39
OCFY20.45%
SpS1.88
BVpS2.7
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.88%
ROE -33.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.77%
FCFM 1.42%
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 46.58
Debt/EBITDA 18.32
Cap/Depr 83%
Cap/Sales 19.12%
Interest Coverage N/A
Cash Conversion 572.81%
Profit Quality N/A
Current Ratio 2.82
Quick Ratio 2.5
Altman-Z -0.54
F-Score5
WACC9.72%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%200%
EPS Next Y-564.1%
EPS Next 2Y-102.47%
EPS Next 3Y-45.89%
EPS Next 5Y35.63%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%0.05%
Revenue Next Year2.76%
Revenue Next 2Y6.02%
Revenue Next 3Y6.94%
Revenue Next 5Y22.46%
EBIT growth 1Y-60.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year236.76%
EBIT Next 3Y65.59%
EBIT Next 5Y46.27%
FCF growth 1Y122.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.15%
OCF growth 3Y16.07%
OCF growth 5Y39.37%